期刊
THYMOSINS IN HEALTH AND DISEASE II
卷 1270, 期 -, 页码 21-27出版社
BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2012.06680.x
关键词
thymosin; thymalfasin; Zadaxin; vaccine; influenza
Thymosin alpha 1 (T alpha 1) is an immune-modulating peptide that can be expected to improve response to vaccinations, as stimulated dendritic cells and T cells can act in concert to increase antibody production along with an improved cytotoxic response from the T cells themselves. T alpha 1 demonstrated efficacy in preclinical studies; subsequently, it was shown to enhance response to vaccinations in difficult-to-treat populations, including individuals immune suppressed due to age or hemodialysis, and leading to a decrease in later infections. During the 2009 pandemic outbreak of H1N1 influenza, mouse and ferret studies confirmed that the use of higher doses of T alpha 1 allowed for fewer injections than those used in the previous clinical studies. In addition, a clinical study with Focetria (TM) MF59-adjuvanted monovalent H1N1 vaccine showed that treatment with T alpha 1 twice provided an earlier and greater response to the vaccine (P < 0.01).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据